menu
    • menu

    Company profile for Castle Biosciences

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatologic cancers. Our tests provide clinically actionable, tumor-specific genomic information to enable more accurate treatment plan decisions. We believe that the traditional approach to developing a treatment plan for dermatologic cancers using clinical and pathology factors alone is inadequate, and can be improved by incorporating persona...
    Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatologic cancers. Our tests provide clinically actionable, tumor-specific genomic information to enable more accurate treatment plan decisions. We believe that the traditional approach to developing a treatment plan for dermatologic cancers using clinical and pathology factors alone is inadequate, and can be improved by incorporating personalized genomic information. All of our tests are performed in a CLIA-certified, CAP-accredited clinical laboratory.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Castle BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    820 S. Friendswood Drive, Suite 201 Friendswood, TX 77546
    Telephone
    Telephone
    866-788-9007
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://castlebiosciences.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/castle-biosciences-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/castlebio?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DecisionDx-Melanoma i31-SLNB Outperforms Staging Criteria
    DecisionDx-Melanoma i31-SLNB Outperforms Staging Criteria

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255641/0/en/Prospective-Multi-center-Study-Published-in-Future-Oncology-Demonstrates-DecisionDx-Melanoma-s-i31-SLNB-Result-Outperforms-Staging-Criteria-in-Identifying-Patients-with-Cutaneous-M.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    DecisionDx-Melanoma Study Shows 2.6% Nodal Positivity Rate
    DecisionDx-Melanoma Study Shows 2.6% Nodal Positivity Rate

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251673/0/en/DecisionDx-Melanoma-s-i31-SLNB-Report-from-the-Largest-Prospective-Multicenter-Study-to-Date-Confirms-2-6-Nodal-Positivity-in-Patients-Predicted-to-Have-Less-Than-5-Risk.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Castle Biosciences To Unveil Decisiondx-Melanoma Data At SSO
    Castle Biosciences To Unveil Decisiondx-Melanoma Data At SSO

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249752/0/en/Castle-Biosciences-to-Present-Data-at-SSO-2026-on-DecisionDx-Melanoma-s-i31-SLNB-Identifying-T1b-T2a-Melanoma-Patients-Who-May-Safely-Avoid-SLNB.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Castle Biosciences Unveils New HQ in Friendswood, Texas
    Castle Biosciences Unveils New HQ in Friendswood, Texas

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248963/0/en/Castle-Biosciences-Announces-Grand-Opening-of-New-Corporate-Headquarters-in-Friendswood-Texas.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    JAAD Study Validates AdvanceAD-Tx in AD
    JAAD Study Validates AdvanceAD-Tx in AD

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3241623/0/en/Prospective-Validation-Study-in-JAAD-Demonstrates-Castle-Biosciences-AdvanceAD-Tx-Test-Identifies-Patients-More-Likely-to-Achieve-Faster-and-Deeper-Responses-with-JAK-Inhibitor-The.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Castle Biosciences To Unveil 2025 Financials, Host Conference
    Castle Biosciences To Unveil 2025 Financials, Host Conference

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232844/0/en/Castle-Biosciences-to-Release-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Host-Conference-Call-on-Thursday-Feb-26-2026.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search